Study Suggests 340B Program Critics Have a Strong Case
The federal government's 340B Drug Pricing Program has had its critics from the very start. Among those critics are pharmaceutical companies who insist that the...
The federal government's 340B Drug Pricing Program has had its critics from the very start. Among those critics are pharmaceutical companies who insist that the...